Bone Turnover and the Osteoprotegerin–RANKL Pathway in Tumor-Induced Osteomalacia: A Longitudinal Study of Five Cases

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

Takashi Shimada, S. Mizutani, Takanori Muto et al. · Proceedings of the National Academy of Sciences · 2001 · 1.5K citations · Full text

Medicine, Oncology, Pathobiology +17

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson et al. · New England Journal of Medicine · 2003 · 920 citations · Full text

Medicine, Endocrinology, Genetics +15

NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION

R. J. Walton, O. L. M. Bijvoet · The Lancet · 1975 · 889 citations

Medicine, Nephrology, Physiology +10

The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group

Daphne Tong, Laurence Gillick, Frank R. Hendrickson · Cancer · 1982 · 796 citations

Medicine, Oncology, Radiation Oncology +16

Disorders of Bone and Mineral Metabolism

F. L. Coe, Murray J. Favus, Jon R. Davids · Journal of Pediatric Orthopaedics · 1992 · 734 citations

Medicine, Nephrology, Bone Metabolism +16